Hikal
Hikal Limited, a prominent player in the pharmaceutical and agrochemical sectors, is headquartered in India. Established in 1988, the company has made significant strides in providing high-quality active pharmaceutical ingredients (APIs) and intermediates, alongside a diverse range of agrochemical products. With a strong operational presence across India and international markets, Hikal has positioned itself as a trusted partner for global pharmaceutical and agricultural companies. Hikal's core offerings include custom synthesis, contract manufacturing, and a robust portfolio of APIs that cater to various therapeutic areas. The company is recognised for its commitment to quality and innovation, which has earned it several industry accolades. As a leader in its field, Hikal continues to drive advancements in sustainable practices and technology, solidifying its reputation as a key contributor to the global healthcare and agriculture landscape.
DitchCarbon Score
How does Hikal's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hikal's score of 16 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hikal's reported carbon emissions
In 2024, Hikal reported total carbon emissions of approximately 21410710 kg CO2e for Scope 1 and 67287010 kg CO2e for Scope 2. This follows a similar trend in 2023, where emissions were about 26793240 kg CO2e for Scope 1 and 67737300 kg CO2e for Scope 2. The company has shown a commitment to reducing its carbon footprint, although specific reduction targets have not been disclosed. Hikal is currently classified as "Committed" to near-term targets, indicating an intention to address its emissions, but it has not set a net-zero target as of now. Hikal operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in India. The company continues to monitor and report its emissions, reflecting a growing awareness of climate impact within the industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 26,793,240 | 00,000,000 | 00,000,000 |
| Scope 2 | 67,737,300 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hikal is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
